To implement an effective but low-cost strategy to decrease SCD maternal and perinatal mortality in Ghana. The objectives are to 1) assess the impact of a multidisciplinary SCD-obstetric team for decreasing mortality across three hospital sites in Ghana. 2) assess the implementation fidelity for 2a) preventing and 2b) treating acute chest syndrome in pregnant women with SCD admitted to the hospital. 3) standardize an ultrasound protocol for the prospective monitoring of fetal growth among pregnant women with SCD.
| Michael DeBaun, MD, MPH | |
| 615-875-3040 | |
| [email protected] |
| Maya Chopra, BA | |
| 614-915-6974 | |
| [email protected] |
18 Years - 45 Years
Observational
Female
Other
All study participants will be adults between the reproductive ages of 18 to 45 years as defined by World Health Organization (WHO)
Confirmed SCD status by Hb-electrophoresis in alkaline medium
Pregnancy should be confirmed by urine or blood pregnancy test and pelvic ultrasound scan.
All pregnant women without a confirmed Hb phenotype or electrophoresis report
All pregnant women with SCD who present to the Greater Accra Regional Hospital or Tamale Teaching Hospital for acute admissions, labor, and delivery
All pregnant women with SCD with undetermined Hb phenotypes on Hb electrophoresis.